Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB1900375	注射用重组改构人肿瘤坏死因子	Recombinant Mutant Human Tumor Necrosis Factor	Lyophilized	Biological Products	Supplementary Application	2019-11-06	上海唯科生物制药有限公司	Shanghai Weike Biopharmaceutical Co Ltd	Certificate Issued	2021-01-19	view
CYSB1700130	注射用重组改构人肿瘤坏死因子	Recombinant Mutant Human Tumor Necrosis Factor	Lyophilized	Biological Products	Supplementary Application	2018-01-16	上海唯科生物制药有限公司	Shanghai Weike Biopharmaceutical Co Ltd	Certificate Issued	2018-06-15	view